Arcadia Biosciences, a trailblazer in the realm of agricultural biotechnology, has made significant strides in the cannabis industry by focusing on the development of high-quality, sustainable plant products. Established in 2002, the company initially aimed to enhance crop productivity and environmental sustainability. However, as the cannabis market burgeoned, Arcadia Biosciences shifted gears to apply its #1excludeGlossary technologies to cannabis cultivation. The name “Arcadia” is derived from a pastoral region in ancient Greece, often associated with unspoiled wilderness and natural beauty, reflecting the company’s commitment to eco-friendly practices. Today, Arcadia Biosciences is renowned for its innovative approaches to plant breeding and genetic improvement, ensuring that it remains a key player in the ever-evolving cannabis landscape. [Source: Arcadia Biosciences Official Website]
 | |
Company type | Public |
|---|---|
| Nasdaq: RKDA | |
| Industry | agricultural biotechnology |
| Founded | 2002 |
| Headquarters | Davis, California, United States |
Area served | Worldwide |
Key people | Matthew Plavan (Chief Executive Officer) |
| Products | GoodWheat™ |
| Revenue |
|
Number of employees | 42 |
| Website | arcadiabio |
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.